Cesarean Scar Defects After Uterine Closure by Double-layer Barbed or Smooth Suture

December 27, 2022 updated by: Fabio Barra, Ospedale Policlinico San Martino

A Prospective Pilot Study Comparing Incidence and Characteristics of Cesarean Scar Defects After Uterine Closure by Double-layer Barbed or Smooth Suture

Late sequelae of a cesarean section related to a uterine scar defects include gynecological symptoms and obstetric complications. The aim of this study was to evaluate the incidence and characteristics of cesarean scar defects after uterine closure by double-layer barbed suture.

Study Overview

Study Type

Observational

Enrollment (Actual)

247

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Genoa, Italy, 16132
        • IRCCS Ospedale Policlinico San Martino

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients who underwent elective cesarean section at ≥37 weeks of gestation

Description

Inclusion Criteria:

- Patients who underwent elective cesarean section at ≥ 37 weeks of gestation

Exclusion Criteria:

  • Patients who underwent concomitant surgical procedures during the cesarean section (i.e., tubal sterilization);
  • Patients who underwent a previous abdominal surgery (with exception of appendectomy) including a cesarean section or other laparotomic/laparoscopic uterine surgical procedure (i.e., myomectomy);
  • Patients who had a previous diagnosis of Mullerian uterine anomalies elective cesarean for the second time or after uterine surgery;
  • Patients who had evidence of PAS disorders or placenta previa.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Low transverse hysterotomy closed by double-layer unidirectional barbed suture
Patients who had undergone cesarean section during which the low transverse hysterotomy was closed by double-layer unidirectional barbed suture
Routinely assessment by objective examination and transvaginal ultrasonographic scan 6, 12, and 24 months after the surgical procedures
Low transverse hysterotomy closed by conventional double-layer smooth suture
Patients who had undergone cesarean section during which the low transverse hysterotomy was closed by conventional double-layer smooth suture
Routinely assessment by objective examination and transvaginal ultrasonographic scan 6, 12, and 24 months after the surgical procedures

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of uterine scar defects
Time Frame: 6 months after the cesarean section
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
6 months after the cesarean section
Number of uterine scar defects
Time Frame: 12 months after the cesarean section
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
12 months after the cesarean section
Number of uterine scar defects
Time Frame: 24 months after the cesarean section
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
24 months after the cesarean section

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 6 months after the cesarean section
RMT, depth, width, and length are evaluated by transvaginal ultrasound
6 months after the cesarean section
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 12 months after the cesarean section
RMT, depth, width, and length are evaluated by transvaginal ultrasound
12 months after the cesarean section
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 24 months after the cesarean section
RMT, depth, width, and length are evaluated by transvaginal ultrasound
24 months after the cesarean section
Number of patients with postmenstrual spotting
Time Frame: 6 months after the cesarean section
Number of patients with postmenstrual spotting is evaluated by medical interview
6 months after the cesarean section
Number of patients with postmenstrual spotting
Time Frame: 12 months after the cesarean section
Number of patients with postmenstrual spotting is evaluated by medical interview
12 months after the cesarean section
Number of patients with postmenstrual spotting
Time Frame: 24 months after the cesarean section
Number of patients with postmenstrual spotting is evaluated by medical interview
24 months after the cesarean section
Number of patients with dysmenorrhea
Time Frame: 6 months after the cesarean section
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
6 months after the cesarean section
Number of patients with dysmenorrhea
Time Frame: 12 months after the cesarean section
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
12 months after the cesarean section
Number of patients with dysmenorrhea
Time Frame: 24 months after the cesarean section
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
24 months after the cesarean section

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fabio Barra, MD, IRCCS Ospedale Policlinico San Martino

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2019

Primary Completion (Actual)

July 30, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

March 27, 2021

First Submitted That Met QC Criteria

March 30, 2021

First Posted (Actual)

April 1, 2021

Study Record Updates

Last Update Posted (Actual)

December 30, 2022

Last Update Submitted That Met QC Criteria

December 27, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BARB-CSCAR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section Complications

Clinical Trials on Clinical and ultrasonographic assessment

3
Subscribe